Is merTK a novel therapeutic target in gastric cancer?
MerTK may be involved in GC carcinogenesis, and it could be a potential novel therapeutic target in GC patients.
This study demonstrates that VLP vaccination provides effective protection against RSV infection. VLPs containing RSV-F and/or RSV-G are potential vaccine candidates against RSV.